164 related articles for article (PubMed ID: 31838139)
1. Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
Medeiros SK; Emery B; Bhagirath V; Parpia S; Dwivedi DJ; Dwivedi NJ; Kearon C; Liaw PC
Thromb Res; 2020 Feb; 186():13-19. PubMed ID: 31838139
[TBL] [Abstract][Full Text] [Related]
2. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception.
Piróg M; Piwowarczyk S; Undas A
Dis Markers; 2019; 2019():4923535. PubMed ID: 31827635
[TBL] [Abstract][Full Text] [Related]
3. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
4. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
Wójcik M; Zaręba L; Undas A
Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
[TBL] [Abstract][Full Text] [Related]
5. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
[TBL] [Abstract][Full Text] [Related]
6. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
7. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
[TBL] [Abstract][Full Text] [Related]
8. Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis.
Bryk AH; Prior SM; Plens K; Konieczynska M; Hohendorff J; Malecki MT; Butenas S; Undas A
Cardiovasc Diabetol; 2019 Apr; 18(1):49. PubMed ID: 30992036
[TBL] [Abstract][Full Text] [Related]
9. Unfavorably altered plasma clot properties in women with a HERDOO2 score equal to or greater than 2 and prediction of recurrent venous thromboembolism.
Mrozińska S; Cieślik J; Broniatowska E; Undas A
Pol Arch Intern Med; 2018 Oct; 128(10):572-579. PubMed ID: 30113019
[TBL] [Abstract][Full Text] [Related]
10. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk.
Ząbczyk M; Natorska J; Janion-Sadowska A; Metzgier-Gumiela A; Polak M; Plens K; Janion M; Skonieczny G; Mizia-Stec K; Undas A
Sci Rep; 2020 Jul; 10(1):11433. PubMed ID: 32651425
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
[TBL] [Abstract][Full Text] [Related]
12. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
Morishima Y; Honda Y
J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
[TBL] [Abstract][Full Text] [Related]
13. Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non-recurrent disease.
Baker SR; Zabczyk M; Macrae FL; Duval C; Undas A; Ariëns RAS
J Thromb Haemost; 2019 Apr; 17(4):618-626. PubMed ID: 30725502
[TBL] [Abstract][Full Text] [Related]
14. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
[TBL] [Abstract][Full Text] [Related]
15. A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism.
Lawrence MJ; Sabra A; Mills G; Pillai SG; Abdullah W; Hawkins K; Morris RH; Davidson SJ; D'Silva LA; Curtis DJ; Brown MR; Weisel JW; Williams PR; Evans PA
Br J Haematol; 2015 Feb; 168(4):571-5. PubMed ID: 25302653
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms.
Gould TJ; Vu TT; Swystun LL; Dwivedi DJ; Mai SH; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1977-84. PubMed ID: 25012129
[TBL] [Abstract][Full Text] [Related]
17. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.
Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K
Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443
[TBL] [Abstract][Full Text] [Related]
18. Unfavourably altered plasma clot properties in patients with primary Raynaud's phenomenon: association with venous thromboembolism.
Żuk J; Snarska-Drygalska A; Malinowski KP; Papuga-Szela E; Natorska J; Undas A
J Thromb Thrombolysis; 2019 Feb; 47(2):248-254. PubMed ID: 30684190
[TBL] [Abstract][Full Text] [Related]
19. Improving fibrinolysis in venous thromboembolism: impact of fibrin structure.
Undas A; Natorska J
Expert Rev Hematol; 2019 Aug; 12(8):597-607. PubMed ID: 31159611
[No Abstract] [Full Text] [Related]
20. Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism.
Martin-Fernandez L; Garcia-Martínez I; Lopez S; Martinez-Perez A; Vilalta N; Plaza M; Moret C; Viñuela A; Brown AA; Panousis NI; Buil A; Dermitzakis ET; Corrales I; Souto JC; Vidal F; Soria JM
Thromb Haemost; 2023 Apr; 123(4):438-452. PubMed ID: 36696913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
